Restoring Insulin Secretion Adult Medication Study
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
- Indications Prediabetic-state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RISE Adult
- 04 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019 as reported by ClinicalTrials.gov record.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Feb 2013 New trial record